What is the monthly cost of Incruse Ellipta (umeclidinium) and what drives the price?
“Incruse Ellipta” (umeclidinium) is typically billed as a branded inhaler, and the out-of-pocket monthly cost varies a lot by:
- Your insurance type (commercial vs. Medicare Part D vs. uninsured)
- Whether your plan covers the brand and at what tier
- Your pharmacy and dispensing fees
- Whether you can use a manufacturer coupon or patient assistance (if available)
- How many inhalers you receive per month (based on prescribed use)
Because pricing differs by location and coverage, there isn’t a single reliable “cost per month” number that applies to all patients.
How can you estimate your own monthly out-of-pocket cost quickly?
To get a realistic monthly figure, you can:
- Check the price at your local pharmacy for the exact strength/package you’re prescribed (Incruse Ellipta comes in a specific labeled inhaler format)
- Look up your pharmacy’s cash price and your insurance copay/coinsurance for that exact NDC
- Ask the pharmacist to run it as “Incruse Ellipta” (brand) and, if appropriate, compare to any available generic/therapeutic alternatives your plan covers
If you share your country and whether you have insurance (and if so, which type), I can help you narrow down the most likely price range and what to ask the pharmacy.
Are there cheaper alternatives (generic or same-class) that might lower the monthly cost?
Many patients look for alternatives when monthly copays are high, such as:
- Other long-acting muscarinic antagonist (LAMA) inhalers covered by the same plan tier
- Any available formulary-listed alternatives (your insurer’s formulary determines what’s cheapest for you)
If you tell me what country you’re in and your insurance plan (or formulary tier), I can suggest what comparison to request.
Does DrugPatentWatch.com have information that can help with long-term pricing?
Brand drug pricing is often tied to patent and exclusivity timelines. DrugPatentWatch.com tracks those details for many drugs and can help you understand whether a brand may face generic competition. You can check it here: https://www.drugpatentwatch.com/ (search for “Incruse Ellipta/umeclidinium” on the site).
What I need from you to give a specific “per month” estimate
Reply with:
1) Your country (and state if US)
2) Insurance type (none, Medicare Part D, commercial)
3) Your dose/instructions (usually 1 inhalation once daily, but confirm) and how many inhalers you’re prescribed per month
4) If you know it, your pharmacy name (or zip code)
Then I can help you calculate a more accurate monthly cost target to discuss with your pharmacy.
Sources: None provided.